Zurueck zur Suche

Reporte zur Charge 3N3CT

Verknuepft ueber VAERS_ID mit VAERSDATA, Vax und Symptoms

7Reporte angezeigt
0Todesfaelle
1Hospitalisiert
1Lebensbedrohlich
0Bleibende Schaeden
MI 2 MO 2 IA 1 VA 1 PA 1

VAERS 2707220

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3N3CT

schwer
Staat
MI
Alter
73,0
Geschlecht
M
Eingang
31.10.2023
Impfdatum
11.10.2023
Beginn
19.10.2023
Tage bis Beginn
8,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: ja Hospital: ja Disable: unbekannt ER: ja Erholt: nein
Acute motor-sensory axonal neuropathy Antiacetylcholine receptor antibody Antibody test negative Areflexia Ascending flaccid paralysis Asthenia Autoantibody negative Borrelia test Borrelia test negative CSF glucose increased CSF protein normal CSF red blood cell count positive CSF white blood cell count negative Corneal reflex decreased Cranial nerve disorder Dyspnoea Electromyogram abnormal Endotracheal intubation

Symptomtext

Client was initially seen at Hospital on 10/19/23 and transferred to another Hospital. He was admitted that same day and required intubation on 10/23/23. He was then transferred to third hospital on 10/27/23 for escalation of care and Neuromuscular evaluation and EMG. Per medical records client presented at hospital emergency department as a transfer from another hospital secondary to abrupt onset of lower extremity weakness upon awakening on 10/19/2023. Patient initially reported mild drift of the lower extremity. Per Telehealth neurology, he was recommended to be seen at hospital for possible anterior spinal artery syndrome and requested MRI brain and spine. Upon arrival to hospital patient was noted to have bilateral lower extremity weakness, absent DTR?s, eventually developed dyspnea and required intubation. He was reportedly also complaining of paresthesias in the distal upper extremities. Weakness rapidly progressed and is now currently involving cranial nerves. Prior to leaving facility, patient was able to move his head and open eyes. A LP was completed on 10/27 which was ?unremarkable?: protein 61, RBC 1400, WBC normal, glucose 102. Five rounds of plasma exchange with no significant improvement. Negative for HIV, Lyme IgG and IgM, paraneoplastic panel, anti-VG CCR antibodies, and anti-ACH receptor antibodies. ?Per report MRI and spine unremarkable in facility.? A neurology consult was placed for ?ascending paralysis with concern for GBS.? Most recent neurology note from 10/30/23 states, ?suspect AIDP variant, likely AMSAN. EMG consistent with diagnosis.? Neurology note from 10/30/23 also reported, ?In bed, not on sedation chronically ill appearing. Patient is unresponsive to verbal, tactile, and noxious stimuli. Breathing synchronous with the ventilator. Pupils are equal and sluggishly reactive to light. Oculocephalic reflex absent. No gaze preference or pathologic nystagmus noted. No corneal reflexes. No facial asymmetry noted. No gag/cough reflex per RN. No spontaneous movements. No withdrawal to noxious stimuli applied to any extremities. No posturing. No tremors, myoclonus, adventitious movements noted. Tone is decreased throughout. Reflexes absent throughout. Plantar responses are mute bilaterally. Prognosis for a functional neurologic recovery is poor.? Multiple other medical conditions being monitored.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Ascending flaccid paralysis
Hospital-Tage
-
Labordaten
Please see narrative above.
Aktuelle Erkrankungen
No documented illnesses reported for client in medical records.
Vorgeschichte
Chronic medical conditions reported as hypertension, seasonal allergies, and hyperlipidemia. Client was a previous tobacco smoker and does drink 2-3 beers per day.
Andere Medikamente
Unknown- no documented home medications, dietary supplements, or herbal remedies in medical records. Client did report to drinking 2-3 beers per day.
Allergien
No known allergies to medications, food, or other products. Client does have seasonal allergies.
Vorherige Impfungen
-

VAERS 2693992

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3N3CT

moderat
Staat
MO
Alter
70,0
Geschlecht
M
Eingang
11.10.2023
Impfdatum
25.09.2023
Beginn
27.09.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Palpitations

Symptomtext

Patient reported that 2 days after his vaccination he experience heart palpitations for 2 to 3 hours in the evening. He felt this was caused by his vaccine because he doesn't frequently have heart palpitations.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Palpitations
Hospital-Tage
-
Labordaten
none
Aktuelle Erkrankungen
-
Vorgeschichte
8 years post triple bypass
Andere Medikamente
atorvastatin 40mg chlorthalidone 25mg famotidine 40mg gabapentin 300mg lisinopril 10mg metformin 500mg metoprolol 25mg potassium 10mg sulfasalazine 500mg vit D2 50,000
Allergien
none reported
Vorherige Impfungen
-

VAERS 2705354

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3N3CT

mild
Staat
MI
Alter
62,0
Geschlecht
M
Eingang
28.10.2023
Impfdatum
07.10.2023
Beginn
09.10.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Rash Rash papular

Symptomtext

Patient states that 2 days after he received the vaccinations he had a rash on both arms that had raised bumps but did not itch.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Rash
Hospital-Tage
-
Labordaten
Saw dermatologist who said it would go away on its own and he said about 3 days later it was gone.
Aktuelle Erkrankungen
Fungal infection on foot
Vorgeschichte
diabetes
Andere Medikamente
metformin, atorvastatin, glimepiride, clonidine, augmentin, carvedilol, lisinopril/hctz, pioglitazone, triamcinolone ointment
Allergien
Penicillin (dad is allergic, listed as an allergy for him) - note when augmentin was filled.
Vorherige Impfungen
-

VAERS 2691435

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3n3ct

mild
Staat
MO
Alter
72,0
Geschlecht
F
Eingang
05.10.2023
Impfdatum
28.09.2023
Beginn
28.09.2023
Tage bis Beginn
0,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: ja
Pruritus Pyrexia

Symptomtext

Fever Day 1 - then intense itching for 5 days

Weitere VAERSDATA-Felder
Praegender Schweregrund
Pruritus
Hospital-Tage
-
Labordaten
was seen by MD - prednisone was given
Aktuelle Erkrankungen
none I am aware
Vorgeschichte
depression
Andere Medikamente
none
Allergien
neomycin
Vorherige Impfungen
-

VAERS 2689654

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3N3CT

mild
Staat
IA
Alter
83,0
Geschlecht
F
Eingang
02.10.2023
Impfdatum
29.09.2023
Beginn
01.10.2023
Tage bis Beginn
2,0
Dosis
1
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Injection site erythema Injection site pruritus

Symptomtext

Patient developed 3 itchy red patches about 3-4 inches across on her arm adjacent to the injection site. They have become more itchy and red over the last 2 days. Patient hasn't taken anything yet, but I instructed her to take benadryl tablets to help with the itching and to monitor the areas to make sure they do not become larger.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Injection site erythema
Hospital-Tage
-
Labordaten
None
Aktuelle Erkrankungen
None
Vorgeschichte
Unknown
Andere Medikamente
Unknown
Allergien
No known medical allergies
Vorherige Impfungen
-

VAERS 2724033

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3N3CT

gering
Staat
VA
Alter
59,0
Geschlecht
F
Eingang
14.12.2023
Impfdatum
11.10.2023
Beginn
01.10.2023
Tage bis Beginn
-
Dosis
N/A
Route/Site
IM / LA
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
No adverse event Product administered to patient of inappropriate age

Symptomtext

There was no adverse event. I was instructed to complete this form as patient was not 60 years old at the time of vaccination. However, patient was 59 years and 10 months old, and has severe (uncontrolled) diabetes and who also recently suffered a central stroke with subsequent speech and motor deficits. Patient is non-language speaking and has a history of no-shows to our clinic. In my medical opinion, patient was appropriate for this vaccine, as not only was she very near the age of 60 but she is extremely susceptible to RSV infection that could prove fatal considering her poor health history. Because she does not consistently come to appointments, it felt appropriate to take advantage of her attendance and provide this important mode of protection despite being 2 months younger than the official requirement.

Weitere VAERSDATA-Felder
Praegender Schweregrund
No adverse event
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
Uncontrolled Type 2 Diabetes, Hypertension, Hyperlipidemia Admission for central stroke 6/2023 (1 week) Dysphasia and weakness following stroke
Vorgeschichte
Uncontrolled Type 2 Diabetes, Hypertension, Hyperlipidemia Admission for central stroke 6/2023 (1 week) Dysphasia and weakness following stroke
Andere Medikamente
Novolin 5 units BID Atorvastatin 80 mg QD Aspirin 81 mg QD Jardiance 25 mg QD Metformin 1000 mg BID Lisinopril 20 mg QD Amlodipine 10 mg QD Trulicity 0.75 mg once weekly
Allergien
None
Vorherige Impfungen
-

VAERS 2714267

GLAXOSMITHKLINE BIOLOGICALS · RSV (AREXVY) · Charge 3N3CT

gering
Staat
PA
Alter
30,0
Geschlecht
F
Eingang
15.11.2023
Impfdatum
04.11.2023
Beginn
04.11.2023
Tage bis Beginn
0,0
Dosis
UNK
Route/Site
- / -
Tod: unbekannt Lebensbedrohlich: unbekannt Hospital: unbekannt Disable: unbekannt ER: unbekannt Erholt: nein
Exposure during pregnancy Product administered to patient of inappropriate age Product use issue Wrong product administered

Symptomtext

pharmacist called to inform that a dose of Arexvy was administered by error to a pregnant woman; 30 year old patient; This non-serious prospective pregnancy case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 30-year-old female patient who received RSVPreF3 adjuvanted (Arexvy) (batch number 3N3CT, expiry date 29-JAN-2025) for prophylaxis. On 04-NOV-2023, the patient received Arexvy. On 04-NOV-2023, an unknown time after receiving Arexvy, the patient experienced inappropriate age at vaccine administration (Verbatim: 30 year old patient). On an unknown date, the patient experienced vaccine exposure during pregnancy (Verbatim: pharmacist called to inform that a dose of Arexvy was administered by error to a pregnant woman). The outcome of the inappropriate age at vaccine administration and vaccine exposure during pregnancy were unknown. Pregnancy exposure: Pregnancy Exposure (Arexvy): To mother in third trimester Pregnancy Details (Neonate 1): Pregnancy Outcome: Pregnancy was ongoing Delivery Notes: around 32-36 weeks gestation Additional Information: GSK Receipt Date: 08-NOV-2023 The reporter stated a dose of Arexvy was administered by error to a 30-year-old pregnant patient, the patient was around 32-36 weeks gestation, which led to inappropriate age at vaccine administration. The vaccine administration facility was the same as primary reporter. The reporter consented to follow up.

Weitere VAERSDATA-Felder
Praegender Schweregrund
Exposure during pregnancy
Hospital-Tage
-
Labordaten
-
Aktuelle Erkrankungen
-
Vorgeschichte
-
Andere Medikamente
-
Allergien
-
Vorherige Impfungen
-